SAGA Diagnostics

About SAGA Diagnostics

SAGA Diagnostics is a biotechnology company focused on early cancer detection through molecular residual disease (MRD) testing. Its flagship Pathlight MRD platform uses tumor-informed, ultra-sensitive blood-based assays to detect circulating tumor DNA across cancer types, enabling clinicians to monitor disease progression and guide treatment decisions. The company collaborates with clinicians, patients, and biopharma partners in the United States and beyond, with a current emphasis on applications in breast cancer and oncology drug development.